22 Nov Bottom-Up Neurotech: Harnessing Sensation to Treat Psychopathology
“We’re seeing converging evidence that not having access to sensation is often a predictor of poor mental health vulnerability....
Newsletter
10 Nov An Open Letter to the Incoming Trump Administration About Psychedelics
A Five Part Plan...
11 Oct Human Flourishing in the Age of Computational Neuroscience
Next week we are publishing a podcast conversation with Shamil Chandaria—a former advisor to Google DeepMind and a research fellow at Imperial College London Centre for Psychedelic Research and Oxford University’s Centre for Eudaimonia and Human Flourishing...
01 Oct Clinic of the Future Part VI: The Potential of Combined Therapies
Over the last few months, we’ve been exploring the hypothetical clinic of the future, focusing on how emerging treatment modalities like psychedelics, transcranial-focused ultrasound, metabolic therapies, and relational practices can synergistically improve mental health care....
13 Sep Clinic of The Future Part V: Metabolic Health Is Mental Health
It’s the food, stupid!...
30 Aug Clinic of the Future Part IV: A Brief Primer on Emergent Neurotechnologies
And some final thoughts on the FDA Decision...
16 Aug The Four Factors of Rejection
Making Sense of the Senseless...
21 Jul The Clinic of the Future Part II: The Relational
Prioritizing the Relational with Communities of Practice...
05 Jul The Clinic of the Future
Relational. Experiential. Energetic. Metabolic....
21 Jun PTSD: Current Treatments & Future Research
The collective sentiment following the now infamous FDA ADCOM meeting about Lykos Therapeutic’s Midomafetamine Assisted-Therapy (AKA MDMA Assisted-Therapy) might be described as ‘on the knife’s edge’ or ‘hanging in the balance’ as we await the final verdict from the FDA on August 11th....